Boostrix Market Report 2026

Boostrix Market Overview

• The Boostrix market growth in the historic period has been driven by established childhood immunization programs, historical outbreaks of pertussis • Market expansion is supported by growing focus on maternal immunization, rising adult booster compliance • Growth Driver: Impact Of Government Initiatives On The Growth Of The Market • North America was the largest region in 2025.

What Is Covered Under Boostrix Market?

Boostrix refers to a vaccine that provides protection against tetanus, diphtheria, and pertussis (whooping cough). It is used for boosting immunity in adolescents and adults, typically as a booster dose following earlier vaccinations in childhood. Boostrix is often recommended during pregnancy to protect newborns from pertussis and in cases where individuals may be at risk of tetanus from injuries. The main indication of boostrix are tetanus, diphtheria, and pertussis (whooping cough). Tetanus is a serious bacterial infection caused by toxins that affect the nervous system, often resulting from wounds contaminated with the bacteria. The various age groups include adolescents, adults, and elderly and distributed through several channels such as hospital pharmacies, retail pharmacies, and online pharmacies. The various end users such as hospitals, and clinics and vaccination centers.

What Is The Boostrix Market Growth Forecast?

The growth in the forecast period can be attributed to growing focus on maternal immunization, rising adult booster compliance, expanding elderly vaccination programs, improved vaccine access through pharmacies, stronger preventive healthcare initiatives. Major trends in the forecast period include rising adult booster vaccination uptake, increased maternal immunization programs, growing awareness of pertussis prevention, expansion of routine booster schedules, strengthening public health immunization coverage.

Global Boostrix Market Segmentation

1) By Indication: Tetanus, Diphtheria, Pertussis (Whooping Cough) 2) By Age Group: Adolescents, Adults, Elderly 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 4) By End User: Hospitals, Clinics And Vaccination Centers

What Are The Drivers Of The Boostrix Market?

The increasing research and development activities are expected to drive the growth of the boostrix market. Research and development activities involve the systematic exploration and development of new knowledge, products, or technologies through research and experimentation. Research and development activities are increasing due to the growing demand for innovative solutions to address emerging health threats and improve treatment efficacy. Research and development activities enhance biorab by driving innovations in rabies prevention and treatment, making it more effective for high-risk populations. They improve vaccine efficacy and safety profiles, supporting wider adoption and better public health outcomes. For instance, in July 2025, according to Eurostat, a Luxembourg-based statistical agency, the total government budget allocations for research and development across the EU reached an estimated €127,916 million in 2024, marking a 3.4% increase compared with €123,675 million in 2023. Therefore, the increasing research and development activities are driving the growth of the boostrix industry. The increasing clinical trials is expected to propel the growth of the boostrix market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety, efficacy, and effectiveness of medical treatments, interventions, drugs, or devices. Clinical trials are increasing due to advancements in medical research and technology, the rising incidence of chronic and complex diseases, and an aging global population that demands new treatments. Clinical trials are highly beneficial for boostrix as they provide critical data to ensure the vaccine’s safety, effectiveness, and ability to protect against pertussis, tetanus, and diphtheria across different age groups. For instance, in February 2024, according to ClinicalTrials.gov, a US-based government web resource, the clinical trial result publications rose from 4,024 in 2022 to 5,063 in 2023. Therefore, increasing clinical trials is driving the growth of the boostrix industry. The rising healthcare expenditure is expected to propel the growth of the boostrix market going forward. Healthcare expenditure refers to the total amount of financial resources spent on healthcare services, including medical treatments, hospital care, medications, and public health initiatives, by governments, businesses, and individuals. The increasing demand for healthcare expenditure is due to the rising prevalence of chronic diseases, which require long-term and costly treatments. Rising healthcare expenditure enhances boostrix adoption by improving access to Tdap vaccination, making it easier for adolescents, adults, and pregnant women to receive protection against tetanus, diphtheria, and pertussis. It supports broader immunization coverage and better public health outcomes. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, total healthcare expenditure saw a 5.6% increase in nominal terms in 2023, an increase of 0.9% growth compared to 2022. Therefore, the rising healthcare expenditure is driving the growth of the boostrix industry.

Key Players In The Global Boostrix Market

Major companies operating in the boostrix market are GSK plc

Regional Insights

North America was the largest region in the boostrix market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Boostrix Market?

The boostrix market consists of sales of boostrix (Tdap) and Boostrix-IPV (Tdap-IPV). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Boostrix Market Report 2026?

The boostrix market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the boostrix industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.